Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-25 @ 9:02 PM
Study NCT ID:
NCT03410056
Status:
TERMINATED
Last Update Posted:
2021-06-22
First Post:
2018-01-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-13
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-03
First Submit QC Date:
None
Study First Post Date:
2018-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-11
Results First Submit QC Date:
None
Results First Post Date:
2021-06-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-11-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-06-10
Last Update Post Date:
2021-06-22
Last Update Post Date Type:
ACTUAL